Compare IMCR & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMCR | ABR |
|---|---|---|
| Founded | 2008 | 2003 |
| Country | United Kingdom | United States |
| Employees | N/A | 653 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2016 | N/A |
| Metric | IMCR | ABR |
|---|---|---|
| Price | $29.55 | $7.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 5 |
| Target Price | ★ $61.82 | $10.30 |
| AVG Volume (30 Days) | 344.3K | ★ 4.1M |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 15.87% |
| EPS Growth | ★ 30.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $249,428,000.00 | N/A |
| Revenue This Year | $14.57 | N/A |
| Revenue Next Year | $8.21 | N/A |
| P/E Ratio | ★ N/A | $9.29 |
| Revenue Growth | ★ 43.05 | N/A |
| 52 Week Low | $23.15 | $7.11 |
| 52 Week High | $40.71 | $12.58 |
| Indicator | IMCR | ABR |
|---|---|---|
| Relative Strength Index (RSI) | 36.35 | 41.57 |
| Support Level | N/A | $7.23 |
| Resistance Level | $34.35 | $8.07 |
| Average True Range (ATR) | 1.14 | 0.23 |
| MACD | -0.10 | -0.06 |
| Stochastic Oscillator | 6.14 | 4.17 |
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.